Impact of Air Pollution on Chronic Respiratory Diseases

Seoul National University

Status: Unknown

Conditions: Asthma; Chronic Obstructive Pulmonary Disease; Idiopathic Pulmonary Fibrosis

Treatments: Other: Non

Study type: Observational

Funder types: Other

Identifiers

NCT03813810

Air_pollution_cohort

Details and patient eligibility

About

The aim of this study is to evaluate the impact of air pollution on the occurrence and clinical course of chronic respiratory diseases, and discover new biomarkers from various devices such as CT images that can indicate the process and amount of lung damage caused by air pollution.

Accordingly, the investigators have designed an prospective cohort with enrollment of normal people and patients with chronic respiratory diseases of three different categories (chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis). Participants will be followed up for a period of one year, with evaluation of the clinical course of the respiratory disease and exposure to air pollution.

Full description

Normal people (n=90) and patients with chronic respiratory diseases (chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, n=90 for each disease) will be enrolled at 5 different institutions in South Korea and followed up for one year. Inspiratory-expiratory CTs and tests including physical examination and blood/urine tests would be performed at the time of enrollment and the time at completion of the follow up period for each participant. Participants would be checked for the residency and working places, as well as checked for the amount of air pollution exposure using a wearable measurement device for 5 days during the study period ( time at enrollment / 3 months / 6 months / 9 months / time at completion). The device would cause no effect on usual daily life or the medical status of the participant. The clinical course such as occurrence of disease, acute exacerbation, decline of lung function, imaging status, mortality would be evaluated as well as the exposure of air pollution for each individual.

Enrollment: 360 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Normal: People with no lung lesions in chest X-ray and St. George's Respiratory Questionnaire score <25, and post bronchodilator FEV1/FVC (forced expiratory volume at one second/forced vital capacity) >= 0.7 and FEV1 >= 80% and FVC >= 80%.
• Chronic obstructive pulmonary disease: Patients with over 10 pack-years of smoking history and post bronchodilator FEV1/FVC <0.7 and FEV1 < 80%, and no other reason for decline of lung function.
• Asthma: Patients with FEV1/FVC < 0.85 and increase in over 12% and 200mL of FEV1 by bronchodilator inhalation. Patients with P20 < 16mg/dL by bronchial provocation test.
• Idiopathic pulmonary fibrosis: Shows usual interstitial pneumonia according to chest CT and has no other reasons such as systematic diseases or medication history.

Exclusion criteria

• Subjects who refused for enrollment in the study
• Subjects who experienced an acute exacerbation within 1 month.
• Subjects under age of 19.

Trial design

360 participants in 4 patient groups

Normal

Description:

People without any chronic pulmonary diseases.

Treatment:

Other: Non

Chronic obstructive pulmonary disease

Description:

Patients with chronic obstructive pulmonary disease.

Treatment:

Other: Non

Asthma

Description:

Patients with asthma

Treatment:

Other: Non

Idiopathic pulmonary fibrosis

Description:

Patients with idiopathic pulmonary fibrosis

Treatment:

Other: Non